Author: medweb
-
Regulating Sodium Channels in Epilepsy
A Northwestern Medicine study uncovered novel findings about sodium channels in neurons that may represent a novel therapeutic target for epilepsy treatment.
-
Students Gather in Support of Affordable Care Act
Close to 200 medical students laid down their white coats at a “White Coats for Coverage” event, in a symbolic gesture of support for the Affordable Care Act.
-
Insights Into Enzyme Targets Could Lead to New Cancer Therapies
Northwestern Medicine scientists have identified the unique targets of two enzymes that activate ubiquitination, a key modification of proteins that controls a variety of cellular processes.
-
Identifying Neural Adaptations Underlying Cocaine Addiction
Northwestern Medicine scientists and co-authors defined a role for the WAVE1 protein in the cellular mechanisms behind cocaine addiction.
-
Celebrating Sex Inclusion in Biomedical Research
Northwestern Medicine hosted a symposium for the one-year anniversary of the implementation of the National Institutes of Health’s landmark sex-inclusion policy.
-
Updating Red Blood Cell Transfusion Guidelines
An article published in JAMA recommends new updates to the red blood cell transfusion guidelines by the American Association of Blood Banks.
-
Housestaff Panel Helps Medical Students Prepare for Residency
A new resident-led program at Northwestern fosters community among underrepresented minority students in undergraduate and graduate medical education programs.
-
Pioneering Astronaut and Physician Keynotes Martin Luther King, Jr. Commemoration
Mae Jemison, MD, a physician and the first woman of color to travel into space, delivered the keynote address during this year’s commemoration of Martin Luther King, Jr.
-
Student Uncovers a Potential Path to Treating Age-Related Memory Loss
A Northwestern Medicine study, led by a PhD student, found that overexpressing a protein called CREB improved memory impairments in aged rats.
-
Clinical Trials Evaluate New Treatment for Anal Cancer
The addition of the drug cetuximab to standard chemoradiation reduced the incidence of relapse for patients with anal cancer, but was associated with significant adverse effects, according to recent Northwestern Medicine clinical trials.
